Additionally, a surgical study found no increased risk of pulmonary complications in GLP1-RA-treated patients with T2D (n = 3,502) compared to patients with T2D who were treated with other antihyperglycaemic medications (n = 23,679) [19], further questioning the need for prolonged perioperative GLP1-RA pausation [10]
Dose adjustments of concomitant diabetes medications may be necessary
Wegovy works well for weight loss
Recommended use: Take 2 capsules 1 to 3 times daily with meals
En ce qui concerne les rsultats secondaires, quatre des cinq essais slectionns ont rapport une rduction significative du poids corporel, de lIMC et des niveaux dhmoglobine glyque chez les participants traits par un agoniste du rcepteur GLP-1
The safety profile of retatrutide is similar to other incretin-based therapies, with the most commonly reported adverse events being transient and mostly mild to moderate gastrointestinal symptoms, with the 4 mg starting dose group having a higher incidence than the 2 mg starting dose group